A Prodrug of Two Approved Drugs, Cisplatin and Chlorambucil, for Chemo War Against Cancer

A Prodrug of Two Approved Drugs, Cisplatin and Chlorambucil, for Chemo War Against Cancer Article

Pathak, Rakesh K, Wen, Ru, Kolishetti, Nagesh et al. (2017). A Prodrug of Two Approved Drugs, Cisplatin and Chlorambucil, for Chemo War Against Cancer . MOLECULAR CANCER THERAPEUTICS, 16(4), 625-636. 10.1158/1535-7163.MCT-16-0445

Open Access

cited authors

Pathak, Rakesh K; Wen, Ru; Kolishetti, Nagesh; Dhar, Shanta

sustainable development goals

SDG 03: Good Health and Well-being

authors

Kolishetti, Nagesh

publication date

April 1, 2017

webpage

https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000398815800007&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=e451fd656366bf1ec5554941920a9ccb

published in

MOLECULAR CANCER THERAPEUTICS Journal

keywords

CELLS
DYSFUNCTION
GLUCOSE-TRANSPORTER-1
GLUTAMINE
GLUTATHIONE
INHIBITION
Life Sciences & Biomedicine
METABOLISM
MITOCHONDRIAL HYPERPOLARIZATION
Oncology
SENSITIVITY
Science & Technology
TARGETED NANOPARTICLES

FIU Discovery

A Prodrug of Two Approved Drugs, Cisplatin and Chlorambucil, for Chemo War Against Cancer Article

Overview

cited authors

sustainable development goals

authors

publication date

webpage

published in

Research

keywords

Identifiers

Digital Object Identifier (DOI)

Additional Document Info

publisher

start page

end page

volume

issue